Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis

Please check out the results of a RCT published in the latest edition of the New England Journal of Medicine, led by CEB PhD student Andrew Lau (pictured above) with Fabian Kong and Jane Hocking from the Sexual Health Unit. It provides conclusive evidence that doxycycline must replace azithromycin as the first line treatment for rectal chlamydia.  https://www.nejm.org/doi/full/10.1056/NEJMoa2031631